Colorectal Cancer With Liver Metastasis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal Cancer With Liver Metastasis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Colorectal Cancer With Liver Metastasis trials you may qualify forThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
This phase III trial compares hepatic arterial infusion (HAI) (pump chemotherapy) in addition to standard of care chemotherapy versus standard of care chemother…
Background: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the…
Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite…
Colorectal cancer (CRC) is a significant cause of morbidity and mortality worldwide. Its early clinical manifestations are often subtle, leading to late-stage d…
To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
This is a prospective, single-center, single-arm exploratory clinical study designed to evaluate the efficacy and safety of hepatic arterial infusion of liposom…
The purpose of this research study is: * To find out how safe the study drug, pembrolizumab, is when combined with stereotactic body radiotherapy (SBRT) to the…